Navigation Links
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
Date:8/6/2009

----------- Initiate ritonavir boosting MAD study in HCV Patients Q3 2009 -------------------------------------------- ------- INFORM-1 presentations at AASLD: Results of all cohorts, PK/PD profile and viral resistance profile November 3, 2009 ----------------------------------------------- ---------------- Rapid Virologic Response (RVR) data from Phase 2b (12-week regimen) Q1 2010 ------------------------------------------------- -------

Other Recent Business Highlights

InterMune expanded its leadership team in support of the anticipated commercialization of pirfenidone and named Barrett McGrath to the newly created position of Vice President of Sales and Marketing. Mr. McGrath has nearly 30 years of experience in the industry, having held leadership positions in sales, marketing and business development at Genentech, DuPont Pharmaceuticals, American Hospital Supply Corporation (now Baxter) and Quintiles Transnational. As a consultant, he has led InterMune's pirfenidone pre-launch team since the spring of 2008.

Guidance for 2009 Revenue and Expenses

The company reiterated its 2009 financial guidance for revenue and operating expenses, which is unchanged from the guidance initially provided on February 26, 2009.

Revenue: 2009 revenue, including Actimmune(R) and anticipated milestone payments from Roche, is expected to be in a range of approximately $40 to $50 million. Actimmune revenue represents approximately 50 percent of this revenue range. The guidance includes an expected $20 million milestone payment from Roche upon initiation of the Phase 2b study of ITMN-191, expected in August.

Operating Exp
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. InterMune to Release Second Quarter Financial Results on August 6
2. InterMune to Present at Goldman Sachs Healthcare Conference
3. InterMune Reports First Quarter 2009 Financial Results and Business Highlights
4. InterMune to Release First Quarter Financial Results on April 30
5. InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25
6. InterMune to Present at Canaccord Adams Hepatitis C Conference
7. InterMune to Present at Citis 4th Annual Biotech Day
8. InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting
9. InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
10. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
11. InterMune Announces Issuance of U.S. Patent for ITMN-191
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... MD (PRWEB) July 29, 2014 ... a vaccine pioneer in the biotechnology industry, announced ... Newport Coast Securities, Inc. to explore financing opportunities ... LAMP-vax technology, a breakthrough vaccine platform with the ... market. The company exclusively licensed the well-established LAMP ...
(Date:7/29/2014)... 29, 2014 DisasterTalk is a texting app ... cell phone masts or other transmitters are down. The app ... away without the need for any Wi-Fi, and can also ... The new app has launched as a housing report ... very high risk of being affected by natural disasters. With ...
(Date:7/29/2014)... The first product launch from start-up ... to robotics. What sets Droidles completely apart from other ... allows them to communicate, share code with each other ... , “The invention is the system,” said Hurley Research ... life of their own, both physically and on the ...
(Date:7/29/2014)... White papers by Clinovo on ... technologies, have been published by leading pharmaceutical publications Data ... line of white papers by Clinovo to have been ... Pharmaceutical Online, and OpenHealthNews. , At the request of ... Marc Desgrousilliers, 'The Five Essentials of Cloud Computing ...
Breaking Biology Technology:Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3DisasterTalk App Could Save Lives as Report Reveals 8% of US Homes at Very High Risk of Natural Disaster 2Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 3
... Instruments, Inc., (http://www.nikoninstruments.com ) is pleased to ... technical support for Nikon,s BioScience Microscopes, Confocal,Systems ... products,including Industrial Microscopes, Measuring and Vision Systems, ... These regions were,previously served by A.G. Heinze, ...
... Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today announced that ... May 13, 2008, following the,close of the U.S. financial ... live audio webcast to discuss the results and,company updates ... p.m.,Pacific Time., The live webcast and press release ...
... May 7 SurgiQuest, Inc. today announced,the first ... the,AirSeal(TM) access system., Drs. Anthony Discuillo and ... in Cambridge, MA. The AirSeal System creates an,invisible ... seals. This provides,unobstructed access to the cavity without ...
Cached Biology Technology:Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories 2Jazz Pharmaceuticals, Inc. to Announce First Quarter Results on May 13, 2008 2SurgiQuest Announces First Single Port Procedure for Ovary Removal Using AirSeal(TM) Access System 2
(Date:7/29/2014)... preterm babies latest research from the University of ... the brains of many preterm children can perform almost as ... by the University,s Robinson Research Institute has found ... injury in early life, their cognitive abilities as a teenager ... However, the results of the study, published in this month,s ...
(Date:7/28/2014)... Food and Drug Administration (FDA) for other purposes can ... human cells, including those that cause Legionnaires, disease, brucellosis, ... mBio , the online open-access journal of the American ... non-antibiotic drugs that could one day help curb bacterial ... list inhibit the growth of at least three of ...
(Date:7/28/2014)... compounds in hydrothermal environments are critical components of the ... deep biosphere, and may have implications for the origins ... minerals influence organic reactions. A team of researchers ... mineral acts as a catalysts for specific hydrothermal organic ... expensive reagents. , At the heart of organic chemistry, ...
Breaking Biology News(10 mins):Preterm children's brains can catch up years later 2New route to identify drugs that can fight bacterial infections 2Mineral magic? Common mineral capable of making and breaking bonds 2Mineral magic? Common mineral capable of making and breaking bonds 3
... 2007 University of California, Irvine scientists have discovered ... in the most common form of mental impairment. ... mutated gene linked to fragile X syndrome blocks brain ... gene -- called fragile X mental retardation 1 (Fmr1) ...
... . , In the ultimatum game - which was ... Institute for Economics in Jena - one person, the proposer, is ... "manna from heaven" with a second person, the responder. The responder ... take home the offered amounts. But if he rejects it, both ...
... to this study. Those who were taught how to translate ... for other beneficial nutrients. , A woman at risk for osteoporosis ... calcium every day. But when she looks at the Nutrition ... of milk, she finds that calcium is only listed by ...
Cached Biology News:UCI researchers restore memory process in most common form of mental disability 2Fair play in chimpanzees 2Got calcium? UWM researcher finds that food labels confuse consumers 2Got calcium? UWM researcher finds that food labels confuse consumers 3
... APAgene kits are designed to rapidly and ... our patented APA Technology. APAgene provides hassle-free, ... price. All necessary ingredients are provided in ... be used for gap filling, localized cloning ...
N,N'-Methylene-bis-acrylamide, Ultra Pure...
... deparaffinize and perform Heat Induced Antigen Retrieval ... mounted on glass microscope slides. Deparffinization is ... high temperature used in HIER (over 90degrees ... by detergent. Formaldehyde fixation impairs or totally ...
... This product is designed to deparaffinize and ... formalin fixed paraffin-embedded tissue sections mounted on ... melting the paraffin at the high temperature ... with emulsification of the paraffin by detergent. ...
Biology Products: